Impact of antibiotic treatment for chronic endometritis on unexplained recurrent pregnancy loss.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
May 2021
Historique:
received: 13 10 2020
revised: 02 12 2020
accepted: 06 12 2020
pubmed: 12 12 2020
medline: 6 11 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

Recurrent Pregnancy Loss (RPL) affects about 1% of all couples and is likely to cause therapeutic vagrancy and psychological distress. Multiple origins can explain RPL, and recent studies suggest the influence of chronic endometritis. The aim of our study is to evaluate the impact of antibiotic treatment on obstetrical prognosis among patients consulting for RPL with isolated chronic endometritis. We conducted a monocentric retrospective comparative study. Patients consulting for RPL, with normal etiologic examinations (except for chronic endometritis), were included. In the case of chronic endometritis, patients could receive antibiotic treatment (14 days of doxycycline and metronidazole). Pregnancy outcomes, collected one year after inclusion, were compared between 3 groups: patients without chronic endometritis, patients with treated chronic endometritis, patients with untreated chronic endometritis. Univariate and multivariate analyses were performed. 42 patients were included. 22 patients had chronic endometritis. Groups were comparable in terms of age, BMI, the number of miscarriages, tobacco consumption, AMH, and FSH levels on day 2. In multivariate analysis, a significant improvement of live birth rate was observed among patients treated for chronic endometritis, compared to the no endometritis group (OR 21.4 [1.93-236.70] p = 0.013) and the untreated endometritis group (OR 24.90 [1.64-376.93] p = 0.020). In our patients examined for RPL, the live birth rate was improved after treatment of chronic endometritis with 14-day antibiotic treatment in comparison to patients with untreated chronic endometritis.

Identifiants

pubmed: 33307243
pii: S2468-7847(20)30410-4
doi: 10.1016/j.jogoh.2020.102034
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Metronidazole 140QMO216E
Doxycycline N12000U13O

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102034

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Camille Gay (C)

Gynecology and Obstetrics Center, AP-HM Hôpital Nord, chemin des Bourrely, 13015, Marseille, France. Electronic address: camille.gay@ap-hm.fr.

Naima Hamdaoui (N)

Gynecology and Obstetrics Center, AP-HM Hôpital Nord, chemin des Bourrely, 13015, Marseille, France; Health Center La Joliette, 63 Avenue Robert Schuman, 13002, Marseille, France.

Vanessa Pauly (V)

Departments of Epidemiology and Health Economics, Clinical Research Unit, Health Research Directorate, AP-HM, 13005, Marseille, France.

Marie-Christine Rojat Habib (MC)

Pathology Laboratory, AP-HM Hôpital de la Timone, 278 rue Saint Pierre, 13005, Marseille, France.

Amina Djemli (A)

Pathology Laboratory, AP-HM Hôpital Nord, chemin des Bourrely, 13015, Marseille, France.

Marion Carmassi (M)

Pathology Laboratory, AP-HM Hôpital Nord, chemin des Bourrely, 13015, Marseille, France.

Cécile Chau (C)

Gynecology and Obstetrics Center, AP-HM Hôpital Nord, chemin des Bourrely, 13015, Marseille, France.

Florence Bretelle (F)

Gynecology and Obstetrics Center, AP-HM Hôpital Nord, chemin des Bourrely, 13015, Marseille, France; Aix Marseille Université, CNRS, IRD, Avignon Université, IMBE UMR 7263, 13397, Marseille, France; Gynecology and Obstetrics Center, AP-HM Hôpital de la Conception, bd Baille, 13005, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH